Related Experiment Video
Updated: Sep 4, 2025

In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
Metabolic remodeling in tumor-associated macrophages contributing to antitumor activity of cryptotanshinone by
Jia-Hau Yen1, Wei-Chieh Huang2,3, Shu-Ching Lin1
1Research Cancer Center for Traditional Chinese Medicine, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
Abstract:
Dampening tumor growth by converting tumor-associated macrophages (TAMs) from M2/repair-types to M1/kill-types is of high interest. Here, we show that cryptotanshinone (CPT) can function as an antitumor immune modulator that switches TAMs from an M2 to an M1 phenotype, leading to tumor regression. An orthotopic triple-negative breast cancer (TNBC) implantation model was used to determine the role and mechanism of CPT in suppressing M1-to-M2 repolarization of TAMs. Co-culturing TNBC cells with CPT-treated macrophages reduced TNBC proliferation and motility, while in TNBC orthotopic mouse models, CPT treatment inhibited breast tumor formation. Moreover, we identified that CPT inhibits mitochondrial oxidative phosphorylation and mitochondrial fusion via autophagy and transcriptional activation of the apoptosis signal-regulating kinase 1 (ASK1) pathway. Suppression of ASK1 downregulates autophagy and abolishes CPT-induced effects upon TAMs. In addition, CPT inhibits M2 macrophage differentiation and causes TRAF6 auto-ubiquitination-dependent activation of the ASK1, leading to M1 polarization. On the contrary, in M1 macrophage, CPT increases interaction of ASK1 and TRAF6 which induces ASK1 ubiquitination and degradation. Intriguingly, CPT plays opposite roles in the M1 and M2 phenotype. Our findings help to illuminate a previously unrecognized antitumor mechanism of CPT and suggest that this natural compound offers a macrophage-based approach for cancer immunotherapy.
Insights
Cryptotanshinone (CPT) converts tumor-associated macrophages (TAMs) from M2 to M1 phenotypes, inhibiting tumor growth. This natural compound offers a novel macrophage-based strategy for cancer immunotherapy.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- Tumor-associated macrophages (TAMs) often exhibit M2/repair phenotypes, promoting tumor growth.
- Repolarizing TAMs to M1/kill phenotypes is a promising cancer immunotherapy strategy.
- Cryptotanshinone (CPT) is a natural compound with potential immunomodulatory effects.
Purpose of the Study:
- To investigate the potential of CPT as an antitumor immune modulator.
- To elucidate the mechanism by which CPT influences TAM polarization.
- To evaluate the efficacy of CPT in preclinical models of triple-negative breast cancer (TNBC).
Main Methods:
- Utilized an orthotopic TNBC implantation mouse model.
- Co-cultured TNBC cells with CPT-treated macrophages.
- Investigated CPT's effects on mitochondrial function, autophagy, and the ASK1/TRAF6 signaling pathway.
- Assessed TAM polarization in response to CPT treatment.
Main Results:
- CPT treatment effectively switched TAMs from M2 to M1 phenotype, leading to tumor regression.
- CPT inhibited TNBC cell proliferation and motility in vitro.
- CPT suppressed tumor formation in vivo and modulated mitochondrial oxidative phosphorylation and fusion.
- CPT's mechanism involves autophagy and the TRAF6-ASK1 pathway, with differential effects on M1 and M2 macrophages.
Conclusions:
- CPT acts as an antitumor immune modulator by repolarizing TAMs to an M1 phenotype.
- CPT's mechanism involves regulating mitochondrial function and the ASK1 pathway.
- CPT demonstrates therapeutic potential as a natural compound for cancer immunotherapy via macrophage-based strategies.
More Related Videos
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
06:38Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...